Showing results (101-110 of 36,324) with videos related to

Sort By:
Pageof 3,633
Frontiers in Oncology|October 19, 2020
The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based AnalysisShibin Cai, Wenjia Zuo, Xunxi Lu, et al.
Frontiers in Oncology|October 19, 2020
Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized TherapyLaura K Esser, Vittorio Branchi, Sonia Leonardelli, et al.
Frontiers in Oncology|October 19, 2020
Seven-Gene Signature Based on Glycolysis Is Closely Related to the Prognosis and Tumor Immune Infiltration of Patients With Gastric CancerShanshan Yu, Chuan Hu, Luya Cai, et al.
Frontiers in Oncology|October 19, 2020
Myeloid Differentiation Primary Response 88-Cyclin D1 Signaling in Breast Cancer Cells Regulates Toll-Like Receptor 3-Mediated Cell ProliferationAradhana Singh, Ranjitsinh Devkar, Anupam Basu
Frontiers in Oncology|October 19, 2020
Carbohydrates, Glycemic Index, and Glycemic Load in Relation to Bladder Cancer RiskHejia Zhu, Qiwang Mo, Haixiang Shen, et al.
Frontiers in Oncology|October 19, 2020
Lack of Racial Survival Differences in Metastatic Prostate Cancer in National Cancer Data Base (NCDB): A Different Finding Compared to Non-metastatic DiseaseToms Vengaloor Thomas, Xiaoshan Z Gordy, Seth T Lirette, et al.
Frontiers in Oncology|October 19, 2020
Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung AdenocarcinomaXiaoguang Qi, Chunyan Qi, Boyu Qin, et al.
Frontiers in Oncology|October 19, 2020
Pancreaticoduodenectomy for Retroperitoneal Sarcomas: A Mono-Institutional Experience in ChinaCheng-Peng Li, Zhen Wang, Bo-Nan Liu, et al.
Frontiers in Oncology|October 19, 2020
Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic SignificanceWenbiao Chen, Xujun Zhang, Kefan Bi, et al.
Frontiers in Oncology|October 19, 2020
Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung CancerChaoyue Su, Hui Wang, Yunru Liu, et al.
Pageof 3,633